Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients

Part of paid clinical trials in Los Angeles, California.

Sponsor
Pfizer
Study ID
NCT01375127
Status
Completed

Conditions

  • Kidney Transplantation

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • Tofacitinib — DRUG
    Subjects who previously took 15 mg BID or 30 mg BID
  • Tofacitinib — DRUG
    Subjects who previously took 15 mg BID for 3 months then 10 mg BID, or 15 mg BID for 6 months then 10 mg BID

Study Details

This is an observational study designed to collect follow-up clinical date on subjects who were treated with tofacitinib in 2 completed Phase 2 studies who either discontinued treatment prematurely or did not elect to enroll in long-term extension studies.

Key Dates

First listed
Jun 17, 2011
Start date
Aug 31, 2011
Status verified
Sep 2013
Primary completion
Jul 31, 2012
Completion
Jul 31, 2012

Study Design

Enrollment
83 participants (actual)

Arms

  • Arm: Subjects from Study A3921009
  • Arm: Subjects from Study A3921030

Primary Outcome Measure

Number of Participants With Clinical Outcome of Post Transplant Lymphoproliferative Disease (PTLD) [ Time Frame: Baseline through Month 12 ]

Locations (23)

FacilityCityStateZIPSite coordinators
Pfizer Investigational SiteLos AngelesCalifornia90024-
Pfizer Investigational SiteLos AngelesCalifornia90095-
Pfizer Investigational SitePalo AltoCalifornia94304-
Pfizer Investigational SiteSan FranciscoCalifornia94115-
Pfizer Investigational SiteSan FranciscoCalifornia94143-
Pfizer Investigational SiteStanfordCalifornia94305-
Pfizer Investigational SiteAuroraColorado80045-
Pfizer Investigational SiteTampaFlorida33606-
Pfizer Investigational SiteChicagoIllinois60611-
Pfizer Investigational SiteChicagoIllinois60637-
Pfizer Investigational SiteBostonMassachusetts02215-
Pfizer Investigational SiteSpringfiledMassachusetts01107-
Pfizer Investigational SiteAnn ArborMichigan48109-
Pfizer Investigational SiteDetroitMichigan48202-
Pfizer Investigational SiteSt LouisMissouri63110-
Pfizer Investigational SiteLivingstonNew Jersey07039-
Pfizer Investigational SiteNew YorkNew York10029-
Pfizer Investigational SiteValhallaNew York10595-
Pfizer Investigational SiteChapel HillNorth Carolina27599-7211-
Pfizer Investigational SiteDallasTexas75204-
Pfizer Investigational SiteDallasTexas75246-
Pfizer Investigational SiteFort WorthTexas76104-
Pfizer Investigational SiteRichmondVirginia23298-

Find similar trials in Los Angeles, CA

By research site
Pfizer Investigational Site· Los Angeles, CAPfizer Investigational Site· Palo Alto, CAPfizer Investigational Site· San Francisco, CAPfizer Investigational Site· Stanford, CAPfizer Investigational Site· Aurora, COPfizer Investigational Site· Tampa, FL

Related Studies